Sort
48,018 grants matching “immunotherapy”
Administrative Core
$737,703Jun Yan · University Of Louisville · P20 · FY2021 · GM
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$737,672Adam Mor · Columbia University Health Sciences · R01 · FY2024 · AI
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$737,672Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$737,605Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2018 · CA
Receptor Mediated T and B Cell Activation
$737,535Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$737,535Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$737,535Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2021 · AI
Immunosuppressive mechanisms responsible for development of non-viral liver cancer and control of its response to immune checkpoint inhibitors
$737,531Michael Karin · University Of California, San Diego · U01 · FY2018 · AA
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
$737,527Robert G Roeder · Rockefeller University · R01 · FY2021 · AI
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
$737,527Sohail Malik · Rockefeller University · R01 · FY2023 · AI
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
$737,527Robert G Roeder · Rockefeller University · R01 · FY2022 · AI
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
$737,527Robert G Roeder · Rockefeller University · R01 · FY2024 · AI
Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis
$737,527Robert G Roeder · Rockefeller University · R01 · FY2020 · AI
Identifying new immunotherapeutic targets for endocrine autoimmunity.
$737,346Maureen A Su · University Of California Los Angeles · U19 · FY2024 · AI
Identifying new immunotherapeutic targets for endocrine autoimmunity.
$737,346Maureen A Su · University Of California Los Angeles · U19 · FY2025 · AI
The role of antibody and the Fc neonatal receptor in transmitted/founder strain selection
$737,266Donald N Forthal · University Of California-Irvine · R01 · FY2016 · AI
CATALYTIC HIV ANTIBODIES
$737,260University Of Texas Hlth Sci Ctr Houston · P01 · FY2002 · AI
Redox Mechanism Process of Angiogenesis and Wound Healing
$737,052David Wink · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Longitudinal Immunological Impact of SARS-CoV-2 Infection
$736,876Timothy Jensen Henrich · University Of California, San Francisco · R01 · FY2021 · AI
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$736,864Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
Evolution of gliomas during treatment and resistance
$736,601Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Molecular Allergy
$736,560Robert E London · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
GCDH Addiction in Melanoma
$736,400Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization
$736,315William Coulis Jason Hunter · Pet/X, Llc · R42 · FY2021 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$736,310Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA